This meta-analysis indicated that lower-grade gliomas had a different genetic aetiology from high-grade tumours and that IDH mutations occurred early in tumour development from a stem cell that can give rise to both astrocytes and oligodendrocytes. Here, IDH2 is linked to central nervous system cancer.